Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data
Tyler Knight,1 Caroline Schaefer,1 Holly Krasa,2 Dorothee Oberdhan,2 Arlene Chapman,3 Ronald D Perrone4 1Covance Market Access Services Inc., Gaithersburg, MD, 2Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, 3Emory University, Atlanta, GA, 4Tufts Medical Center and Tuf...
Saved in:
Main Authors: | Knight T (Author), Schaefer C (Author), Krasa H (Author), Oberdhan D (Author), Chapman A (Author), Perrone RD (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The societal economic burden of autosomal dominant polycystic kidney disease in the United States
by: Martin Cloutier, et al.
Published: (2020) -
Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease
by: Iyer NN, et al.
Published: (2018) -
Autophagy and Autosomal Dominant Polycystic Kidney Disease
by: Özgür Akın Oto, et al.
Published: (2023) -
Autosomal dominant polycystic kidney disease: updated perspectives
by: Rastogi A, et al.
Published: (2019) -
Obturator hernia in autosomal dominant polycystic kidney disease
by: Jong Hwan Jung, et al.
Published: (2018)